Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
17.10
+0.70 (4.27%)
Oct 15, 2025, 3:22 PM EDT - Market open
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $11.68 billion as of October 15, 2025. Its market cap has increased by 37.55% in one year.
Market Cap
11.68B
Enterprise Value
7.03B
1-Year Change
37.55%
Ranking
Category
Stock Price
$17.10
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $11.68B, an increase of 2,089.31%. That is a compound annual growth rate of 88.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 11.20B | 30.05% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
| Dec 8, 2020 | 533.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |